tiprankstipranks
Trending News
More News >
Prelude Therapeutics (PRLD)
NASDAQ:PRLD
US Market

Prelude Therapeutics (PRLD) Revenue

Compare
139 Followers

Prelude Therapeutics Revenue

Prelude Therapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2025, with -100.00%. This bring the company's revenue in the last twelve months to 7.00M, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, Prelude Therapeutics had annual revenue of 7.00M with Infinity% growth.
Revenue (ttm)
7.00M
Revenue Growth
P/S Ratio
7.74
Revenue/Employee
$53,435
Employees
131
Market Cap
$54.21M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
7.00M+∞%
Dec 31, 2023
0.00
Dec 31, 2022
0.00
Dec 31, 2021
0.00
Dec 31, 2020
0.00
Dec 31, 2019
0.00
Dec 31, 2018
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis